| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/25/2005 | WO2004043988A8 Ptprk immunogenic peptide |
| 08/25/2005 | WO2003086307A3 β2-MICROGLOBILIN (β2m) AND ANTI-β2m BINDING AGENTS AS ANTI-CANCER THERAPEUTICS |
| 08/25/2005 | US20050188433 Expression vector comprising nucleotide sequences coding succinate/fumarate-transport protein for use generating and propagating plants with enhanced germination behavior |
| 08/25/2005 | US20050187716 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 08/25/2005 | US20050187382 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/25/2005 | US20050187380 Method for treating Th2-mediated disease |
| 08/25/2005 | US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/25/2005 | US20050187179 treatment of tumors which have increased Notch expression; administration of either Notch antisense oligonucleotides or monoclonal antibodies directed to Notch along with cell differentiating agent |
| 08/25/2005 | US20050187159 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability, therapy |
| 08/25/2005 | US20050187152 Prevention and treatment of hypergastrinemia |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186663 Cystine-knot fold protein |
| 08/25/2005 | US20050186662 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders |
| 08/25/2005 | US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 08/25/2005 | US20050186658 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/25/2005 | US20050186644 Contacting a sample comprising bladder cells taken from the subject with an antibody that specifically binds to nuclear matrix protein BLCA-4, wherein bladder cancer or risk of developing bladder cancer is indicated if sample contains nuclear matrix protein BLCA-4 |
| 08/25/2005 | US20050186641 immobilized poly(amino acids) are labeled or detected on blots or on arrays of poly(amino acids), or are attached to immobilized aptamers; use in analysis and diagnostics |
| 08/25/2005 | US20050186637 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders |
| 08/25/2005 | US20050186623 Recovering immunoglobulins from hybridoma cell line; bioreactor and heterologous gene expression |
| 08/25/2005 | US20050186622 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 08/25/2005 | US20050186618 ADAM gene having a novel base sequence; an ADAM protein encoded by it has the protease activity and is involved in degradation of an extracellular matrix; recombinant vector comprising the DNA; recombinant host cell |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186562 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time |
| 08/25/2005 | US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186264 Targeting drug/gene carriers to irradiated tissue |
| 08/25/2005 | US20050186216 Binding domain-immunoglobulin fusion proteins |
| 08/25/2005 | US20050186215 CUDR as biomarker for cancer progression and therapeutic response |
| 08/25/2005 | US20050186214 Antiproliferative agents; chimeric molecules to direct cytotoxins, imaging reagents, and drugs; cells, kits |
| 08/25/2005 | US20050186213 Anti-PECAM therapy for metastasis suppression |
| 08/25/2005 | US20050186212 Trefoil factor 3 (TFF3) as a target for anti-cancer therapy |
| 08/25/2005 | US20050186211 Use of mda-5 as an antiviral and antiproliferative agent |
| 08/25/2005 | US20050186208 Anti-neoplastic composition of adrenocorticosteroides, progestins, estrogens, antiestrogen, androgens; breast cancer, colorectal cancer, rectal cancer, non-small cell lung cancer, non-Hodgkins lymphoma (NHL), renal cell cancer, prostate cancer, liver cancer, pancreatic cancer, soft-tissue sarcoma |
| 08/25/2005 | US20050186206 Administering a CD20 antagonist antibody; autoimmune disease |
| 08/25/2005 | US20050186205 Administering unlabelled anti-CD20 antibody that binds to the CD20 antigen present on lymphoma cells; a second treatment of cyclophosphamide, doxorubicin, vincristine or prednisone |
| 08/25/2005 | US20050186204 Antagonists of placental growth factor receptor and signaling; preventing bone loss and/or enhancing bone healing |
| 08/25/2005 | US20050186203 Isolated antibody bound to human insulin-like growth factor-I receptor, identification of its CDRs (complementarity-determining regions), inhibiting the tyrosine kinase activity of the IGF-IR receptor |
| 08/25/2005 | US20050186202 Mouse-human chimeric variants of CC49 with minimal murine content in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present |
| 08/25/2005 | US20050186201 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 08/25/2005 | US20050186187 Altering the expression levels of a protein; modulating the activity of secretory leukocyte protease inhibitor (SLPI), CD53, or Transferrin-1 in a cell and culturing the cells |
| 08/25/2005 | US20050186136 Soluble JAM-1, 2, and 3 as diagnostic & prognostic markers in cardiovascular, vascular, and inflammatory disorders |
| 08/25/2005 | US20050185135 Electro-active spectacle employing modal liquid crystal lenses |
| 08/25/2005 | CA2819492A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2561531A1 Inhibition of factor b, the alternative complement pathway and methods related thereto |
| 08/25/2005 | CA2555864A1 Antibody for diagnosing and treating neuropsychiatric diseases, in particular schizophrenia, depression and bipolar affective disorders |
| 08/25/2005 | CA2555848A1 Antibody targeting osteoclast-associated protein |
| 08/25/2005 | CA2555791A1 Highly concentrated liquid formulations of anti-egfr antibodies |
| 08/25/2005 | CA2555789A1 Ctgf as target for the therapy of diabetic nephropathy |
| 08/25/2005 | CA2555699A1 Monoclonal antibody based biomarker discovery and development platform |
| 08/25/2005 | CA2555666A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2555503A1 Humanized anti-cd3 bispecific binding molecules having reduced immunogenicity, uses and compositions relating thereto |
| 08/25/2005 | CA2555393A1 Hybrid proteins of active-site serine beta-lactamase |
| 08/25/2005 | CA2555365A1 Methods and compositions for treating tumors and metastatic disease |
| 08/25/2005 | CA2555319A1 Inhibiting cav3 isoforms and the .delta.25b splice variants for the diagnosis and treatment of cancer |
| 08/25/2005 | CA2554978A1 Anti-cd3 and antigen-specific immunotherapy to treat autoimmunity |
| 08/25/2005 | CA2554971A1 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 08/25/2005 | CA2554380A1 Mecp2e1 gene |
| 08/25/2005 | CA2549432A1 Lipid rafts and clostridial toxins |
| 08/24/2005 | EP1566636A1 Use of Tweak modulators and inhibitors for the treatment of neurological conditions |
| 08/24/2005 | EP1566635A1 Microwell array chip for detecting antigen-specific lymphocyte, method of detecting antigen-specific lymphocyte and method of cloning antigen-specific lymphocyte antigen receptor gene |
| 08/24/2005 | EP1566453A2 Qualitative differential splicing |
| 08/24/2005 | EP1566442A2 Preparation and use of a human antibody gene bank (human antibody libraries) |
| 08/24/2005 | EP1566439A1 Preventing or treating obesity |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1566202A1 Use of resistin antagonists in the treatment of rheumatoid arthritis |
| 08/24/2005 | EP1565581A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/24/2005 | EP1565567A2 Method for the selection of cells producing specifically binding molecules |
| 08/24/2005 | EP1565564A2 Modified antibodies stably produced in milk and methods of producing same |
| 08/24/2005 | EP1565559A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 08/24/2005 | EP1565558A2 Method for isolating intracellular antibodies able to neutralize protein interactions |
| 08/24/2005 | EP1565553A2 Recombinant catalytic polypeptides and their uses |
| 08/24/2005 | EP1565495A2 Anti-activated ras antibodies |
| 08/24/2005 | EP1565494A2 Cd55-interaction partners and the uses thereof |
| 08/24/2005 | EP1565493A2 Antibody for the thyrotropin receptor and uses thereof |
| 08/24/2005 | EP1565492A1 Identification of tsh receptor autoantibodies using affinity-purified antibodies |
| 08/24/2005 | EP1565491A2 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis |
| 08/24/2005 | EP1565490A2 Holo-transcobalamins binding partners and their use in cobalamin assay |
| 08/24/2005 | EP1565489A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565482A2 A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same |
| 08/24/2005 | EP1565478A2 Polysaccharide vaccine for staphylococcal infections |
| 08/24/2005 | EP1565213A2 Treatment of prion-induced diseases by administration of anti-prion antibodies |
| 08/24/2005 | EP1565208A1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565080A2 Novel immunogenic proteins of leptospira |
| 08/24/2005 | EP1088228B1 Cartilage resorption assays |
| 08/24/2005 | EP1038014B1 VEGETABLE (GntI) SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | CN1659440A Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659437A Method for mapping and eliminating T-cell epitopes |
| 08/24/2005 | CN1659280A La1 - the genome of a lactobacillus strain |
| 08/24/2005 | CN1659277A Novel phospholipases and uses thereof |
| 08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 08/24/2005 | CN1659274A Cytokine receptor |
| 08/24/2005 | CN1659186A Antibodies to adipose tissues |
| 08/24/2005 | CN1659185A Method for producing monoclonal antibodies |
| 08/24/2005 | CN1658906A Mycoplasma polypeptides |